Aroa Biosurgery Ltd (AU:ARX) has released an update.
Aroa Biosurgery Limited has announced a new proposal to issue a total of 961,255 Performance Rights securities. Scheduled for the 23rd of July, 2024, this move aims to enhance the company’s financial flexibility. Interested parties should note that this proposal is currently awaiting confirmation from the ASX for security code and quotation on the deferred settlement basis.
For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.